A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
LIC MF Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
89.05% ↑
NAV (₹) on 23 Jun 2026
34.71
1 Day NAV Change
0.66%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum ... Read more
NAV History
Fund Details
Min. SIP Amount
₹200
Inception Date
08 Feb 2019
Min. Lumpsum Amount
₹ 5,000
Fund Age
7 Yrs
AUM
₹ 88.96 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.13%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 88.96 Cr
Equity
478.05%
Money Market & Cash
23.66%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 60.58% |
| Hospitals & Medical Services | 26.95% |
| Treps/Reverse Repo | 7.29% |
| Chemicals - Others | 5.38% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.61% | ₹ 9.43 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 7.56% | ₹ 6.72 | Pharmaceuticals |
| Treps | 7.29% | ₹ 6.49 | Others |
| Apollo Hospitals Enterprise Ltd. | 6.63% | ₹ 5.90 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 6.51% | ₹ 5.79 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 5.49% | ₹ 4.89 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 5.38% | ₹ 4.79 | Chemicals - Others |
| Aurobindo Pharma Ltd. | 4.98% | ₹ 4.43 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 4.49% | ₹ 4 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 3.55% | ₹ 3.16 | Pharmaceuticals |
| Zydus Lifesciences Ltd. | 3.15% | ₹ 2.80 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 3.08% | ₹ 2.74 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 3.07% | ₹ 2.73 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 3.07% | ₹ 2.73 | Hospitals & Medical Services |
| Biocon Ltd. | 3.06% | ₹ 2.72 | Pharmaceuticals |
| Global Health Ltd. | 2.97% | ₹ 2.65 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 2.95% | ₹ 2.63 | Hospitals & Medical Services |
| Artemis Medicare Services Ltd. | 2.87% | ₹ 2.56 | Hospitals & Medical Services |
| IPCA Laboratories Ltd. | 2.85% | ₹ 2.53 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.29% | ₹ 2.04 | Pharmaceuticals |
| Acutaas Chemicals Ltd. | 2.22% | ₹ 1.97 | Pharmaceuticals |
| Anthem Biosciences Ltd. | 2.16% | ₹ 1.93 | Pharmaceuticals |
| Dr Agarwal's Health Care Ltd. | 2.15% | ₹ 1.92 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 1.82% | ₹ 1.62 | Hospitals & Medical Services |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 7.17% | 12.64% | 14.36% | 23.65% |
| Category returns | 2.75% | 6.12% | 7.36% | 22.15% |
Fund Objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
AMC Details
Name
LIC Mutual Fund Asset Management Limited
Date of Incorporation
20 Apr 1994
CEO
Mr. Ravi Kumar Jha
CIO
Mr. Nikhil Rungta,Mr. Yogesh Patil
Type
Institution
Address
4th Floor,
Industrial Assurance Building,
Opp. Churchgate Station Mumbai, Maharashtra, India - 400020
Website
http://www.licmf.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.61 | 207.54% | 342.27% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.61 | 207.54% | 342.27% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.61 | 207.54% | 342.27% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.09 | 203.36% | 324.28% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.09 | 203.36% | 324.28% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.09 | 203.36% | 324.28% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.69 | 15.58% | 205.84% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.69 | 15.58% | 205.84% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.69 | 15.58% | 205.84% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.66 | 14.42% | 195.79% | 0.00% | ₹9,724 | 1.75% |
Very High
|
Top Funds from LIC Mutual Fund Asset Management Limited
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Gold ETF
ETF
Regular
|
₹129.63 | 44.38% | 141.96% | 196.00% | ₹1,470 | 0.45% |
High
|
|
LIC MF Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹39.29 | 43.36% | 139.58% | 192.76% | ₹824 | 0.35% |
High
|
|
LIC MF Gold ETF FOF
Fund of Funds
Regular
|
₹37.16 | 42.90% | 136.80% | 187.00% | ₹824 | 0.61% |
High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹64.13 | 13.90% | 117.49% | 213.07% | ₹1,099 | 0.81% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹62.97 | 13.89% | 117.24% | 211.61% | ₹1,099 | 0.81% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹62.97 | 13.89% | 117.24% | 211.61% | ₹1,099 | 0.81% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹55.40 | 12.31% | 109.23% | 194.26% | ₹1,099 | 2.17% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹55.41 | 12.31% | 109.23% | 194.25% | ₹1,099 | 2.17% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹55.41 | 12.31% | 109.23% | 194.25% | ₹1,099 | 2.17% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹34.72 | 12.65% | 89.11% | 80.55% | ₹89 | 1.13% |
Very High
|
FAQs
What is the current NAV of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
The current Net Asset Value (NAV) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹34.71 as of 23 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
The Assets Under Management (AUM) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹88.96 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment has delivered returns of 12.64% (1 Year), 23.65% (3 Year), 12.54% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
The minimum lumpsum investment required for LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹200, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
Mutual Funds: Why Two to Three Well-Chosen Schemes Beat a Large, Overlapping Basket -
Mutual funds: Why 2-3 Well-Chosen Investments Beat Large, Overlapping Portfolios for Retail Investors
-
Why Most Investors Should Stop At 2-3 Mutual Funds
-
Zerodha Launches Life Cycle Funds To Bring Target Date Investment For Indians | Here’s How It Works -
These 5 Small-Cap Mutual Funds Delivered Over 27% Returns in 3 Years: Check Full List -
Top Aggressive Hybrid Mutual Funds to Consider in June 2026: A Simple Guide for Steady Growth -
What Happens If You Miss Stock Market's Best Days? FundsIndia Reveals Shocking Impact -
Tata Gold ETF: AMC Limits Direct Subscriptions And Lumpsum Inflows From June 8 -
Your Portfolio Can Pay You Every Single Month -
Good Returns: Everyone Wants The “Latest Launch”. But Does That Always Mean Better Value?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+